aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...
aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ... aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...
pegilirebuli interferonis da ribavirinis dozis cvlilebebi mkurnalobis dros ganviTarebuli hematologiuri cvlilebebis dros ribavirinis Semcireba 600 mg -mde medikamentebis dozis cvlilebebi ribavirin is Sewyveta PEG-IFN-is Semcireba 70%,50%, 25%-iT PEG-IFN Sewyveta neitrofilebi
menejmenti gverdiTi movlenebi antidepresantebi (seleqtiuri serotoninis ukumitacebis inhibitori) Tireoiduli hormoni klinikurad gamoxatuli depresiis SemTxvevaSi(ΑΙΙ) hipoTireozis dros (AII). β-blokatorebi hiperTireozis dros (CIII). • Tanmxlebi antiretrovirusuli medikamentebis gamoyeneba. PEG- intrferoniT da ribaviriniT kombinirebuli mkurnalobis dros cirozian avadmyofebSi didanozini (ddI) ukunaCvenebia(EI) da aseve sasurvelia ar iqnas gamoyenebuli RviZlis naklebad mZime dazianebis dros.(EII). PEG- intrferoniT da ribaviriniT kombinirebuli mkurnalobis dros stavudini (d4T) gansakuTrebiT didanozinTan(ddI) kombinaciaSi ar unda iqnas gamoyenebuli, radgan am dros izrdeba laqtat acidozis ganviTarebis riski.(EII). aseve HCV –s kombinirebuli antivirusuli mkurnalobis dros HIV koinfeqciiT avadmyofebSi zidovudinis gamoyenebisgan Tavi unda iqnas Sekavebuli, radgan zidovudini zrdis anemiis da neitropeniis ganviTarebis risks(DII). PI –s gamoyeneba amcirebs myari virusuli pasuxis(SVR) ganviTarebis albaTobas HIV/HCV ko-infeqciiT avadmyofebSi, Tumca jer-jerobiT kategoriuli uaryofiTi rekomendaciebi PI –s gamoyenebis mimarT ar aris. NVP (nevirapini) sifrTxiliT unda iqnas gamoyenebuli(AII). 6. reabilitacia da dakvirveba HCV antivirusul mkurnalobaze myofi avadmyofebis monitoringi, mkurnalobis tolerantobis da mkurnalobis efeqturobis Sefasebis mizniT maCveneblebi 1,2 4 8 12 16 20 24 28 32 34 36 48 72 mkurnalobis tolerantoba sisxlis saerTo Trombocite X X X X X X X X X X X X X 195
- Page 144 and 145: laboratoriuli monacemebis kontroli
- Page 146 and 147: Tirkmlis funqciuri sinjebi, gulmker
- Page 148 and 149: aiv infeqcia/Sidsis fonze ganviTare
- Page 150 and 151: aiv infeqcia/Sidsis fonze ganviTare
- Page 152 and 153: 6. reabilitacia da dakvirveba monit
- Page 154 and 155: kandidozuri ezofagitis SemTxvevebSi
- Page 156 and 157: aiv infeqcia/Sidsis fonze ganviTare
- Page 158 and 159: aiv infeqcia/Sidsis fonze ganviTare
- Page 160 and 161: aiv infeqcia/Sidsis fonze ganviTare
- Page 162 and 163: aiv infeqcia/Sidsis fonze ganviTare
- Page 164 and 165: aiv infeqcia/Sidsis fonze ganviTare
- Page 166 and 167: aiv infeqcia/Sidsis fonze ganviTare
- Page 168 and 169: martivi herpesvirusuli infeqciis mZ
- Page 170 and 171: meTodiT, sisxlis saerTo analizi, Rv
- Page 172 and 173: )gamomricxavi _ aiv infeqcia/Sidsis
- Page 174 and 175: aiv infeqcia/Sidsis fonze ganviTare
- Page 176 and 177: aiv infeqcia/Sidsis fonze ganviTare
- Page 178 and 179: aiv infeqcia/Sidsis fonze ganviTare
- Page 180 and 181: aiv infeqcia/Sidsis fonze ganviTare
- Page 182 and 183: aiv infeqcia/Sidsis fonze ganviTare
- Page 184 and 185: aiv infeqcia/Sidsis fonze ganviTare
- Page 186 and 187: aiv infeqcia/SidsiT avadmyofebSi B
- Page 188 and 189: dinamikaSi dakvirveba CD4≥500/mm
- Page 190 and 191: HBV mkurnalobis efeqturoba HBeAg (+
- Page 192 and 193: ) gamomricxavi - aiv infeqcia/Sidsi
- Page 196 and 197: i CD4 X X X X X X X X X TSH X X X H
- Page 198 and 199: )gamomricxavi - aiv infeqcia/Sidsis
- Page 200 and 201: pirveli rigis antituberkulozuri med
- Page 202: testebi: • sisxlis saerTo analizi
menejmenti<br />
gverdiTi movlenebi<br />
antidepresantebi<br />
(seleqtiuri serotoninis<br />
ukumitacebis inhibitori)<br />
Tireoiduli hormoni<br />
klinikurad gamoxatuli depresiis SemTxvevaSi(ΑΙΙ)<br />
hipoTireozis dros (AII).<br />
β-blokatorebi<br />
hiperTireozis dros (CIII).<br />
• Tanmxlebi antiretrovirusuli medikamentebis<br />
gamoyeneba.<br />
PEG- intrferoniT <strong>da</strong> ribaviriniT kombinirebuli mkurnalobis dros<br />
cirozian avadmyofebSi di<strong>da</strong>nozini (ddI) ukunaCvenebia(EI) <strong>da</strong> aseve<br />
sasurvelia ar iqnas gamoyenebuli RviZlis naklebad mZime <strong>da</strong>zianebis<br />
dros.(EII).<br />
PEG- intrferoniT <strong>da</strong> ribaviriniT kombinirebuli mkurnalobis dros<br />
stavudini (d4T) gansakuTrebiT di<strong>da</strong>nozinTan(ddI) kombinaciaSi ar un<strong>da</strong><br />
iqnas gamoyenebuli, radgan am dros izrdeba laqtat acidozis<br />
ganviTarebis riski.(EII).<br />
aseve HCV –s kombinirebuli antivirusuli mkurnalobis dros HIV koinfeqciiT<br />
avadmyofebSi zidovudinis gamoyenebisgan Tavi un<strong>da</strong> iqnas<br />
Sekavebuli, radgan zidovudini zrdis anemiis <strong>da</strong> neitropeniis<br />
ganviTarebis risks(DII).<br />
PI –s gamoyeneba amcirebs myari virusuli pasuxis(SVR) ganviTarebis<br />
albaTobas HIV/HCV ko-infeqciiT avadmyofebSi, Tumca jer-jerobiT<br />
kategoriuli uaryofiTi rekomen<strong>da</strong>ciebi PI –s gamoyenebis mimarT ar aris.<br />
NVP (nevirapini) sifrTxiliT un<strong>da</strong> iqnas gamoyenebuli(AII).<br />
6. reabilitacia <strong>da</strong> <strong>da</strong>kvirveba<br />
HCV antivirusul <strong>mkurnaloba</strong>ze myofi avadmyofebis<br />
monitoringi, mkurnalobis tolerantobis <strong>da</strong> mkurnalobis<br />
efeqturobis Sefasebis mizniT<br />
maCveneblebi<br />
1,2 4 8 12 16 20 24 28 32 34 36 48 72<br />
mkurnalobis<br />
tolerantoba<br />
sisxlis<br />
saerTo<br />
Trombocite X X<br />
X X X X X X X X X X X<br />
195
Change language